Smoking is highly prevalent among individuals with mental health disorders, posing significant health risks. This article explores two pharmacological options—cytisine and nicotine replacement therapy (NRT)—used to aid smoking cessation in psychiatric inpatient settings.
Understanding the effectiveness and safety of these treatments can help inform clinical practices and public health strategies aimed at reducing smoking rates among vulnerable populations.